vs
Side-by-side financial comparison of Nextdoor Holdings, Inc. (NXDR) and RHYTHM PHARMACEUTICALS, INC. (RYTM). Click either name above to swap in a different company.
Nextdoor Holdings, Inc. is the larger business by last-quarter revenue ($61.7M vs $60.1M, roughly 1.0× RHYTHM PHARMACEUTICALS, INC.). Nextdoor Holdings, Inc. runs the higher net margin — -18.5% vs -92.6%, a 74.0% gap on every dollar of revenue. On growth, RHYTHM PHARMACEUTICALS, INC. posted the faster year-over-year revenue change (83.8% vs 13.8%). Over the past eight quarters, RHYTHM PHARMACEUTICALS, INC.'s revenue compounded faster (43.8% CAGR vs -1.3%).
Nextdoor Holdings, Inc. is an American company that operates a hyperlocal social networking service for neighborhoods. The company was founded in 2008 and is based in San Francisco, California. Nextdoor launched in the United States in October 2011. It is available in eleven countries as of May 2023. In 2024, the company claimed to have 88 million "neighbors" as members.
Rhythm Pharmaceuticals is a biopharmaceutical firm focused on developing and commercializing targeted therapies for rare genetic disorders causing severe unmanageable obesity, including POMC deficiency, LEPR deficiency, and Bardet-Biedl syndrome. It serves patients in North America and Europe who lack effective standard treatments for their chronic life-altering conditions.
NXDR vs RYTM — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $61.7M | $60.1M |
| Net Profit | $-11.4M | $-55.6M |
| Gross Margin | — | 88.1% |
| Operating Margin | — | -87.1% |
| Net Margin | -18.5% | -92.6% |
| Revenue YoY | 13.8% | 83.8% |
| Net Profit YoY | 48.0% | — |
| EPS (diluted) | — | $-0.83 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $61.7M | $60.1M | ||
| Q4 25 | $69.5M | $57.3M | ||
| Q3 25 | $68.9M | $51.3M | ||
| Q2 25 | $65.1M | $48.5M | ||
| Q1 25 | $54.2M | $32.7M | ||
| Q4 24 | $65.2M | $41.8M | ||
| Q3 24 | $65.6M | $33.3M | ||
| Q2 24 | $63.3M | $29.1M |
| Q1 26 | $-11.4M | $-55.6M | ||
| Q4 25 | $-4.0M | $-47.5M | ||
| Q3 25 | $-12.9M | $-52.9M | ||
| Q2 25 | $-15.4M | $-46.6M | ||
| Q1 25 | $-22.0M | $-49.5M | ||
| Q4 24 | $-12.1M | $-43.3M | ||
| Q3 24 | $-14.9M | $-43.6M | ||
| Q2 24 | $-42.8M | $-32.3M |
| Q1 26 | — | 88.1% | ||
| Q4 25 | 84.9% | 91.6% | ||
| Q3 25 | 84.9% | 89.3% | ||
| Q2 25 | 83.6% | 88.6% | ||
| Q1 25 | 82.6% | 88.8% | ||
| Q4 24 | 84.0% | 90.9% | ||
| Q3 24 | 83.0% | 88.5% | ||
| Q2 24 | 83.8% | 89.9% |
| Q1 26 | — | -87.1% | ||
| Q4 25 | -10.7% | -82.2% | ||
| Q3 25 | -25.0% | -102.6% | ||
| Q2 25 | -31.1% | -93.4% | ||
| Q1 25 | -49.9% | -143.7% | ||
| Q4 24 | -26.2% | -98.6% | ||
| Q3 24 | -31.7% | -132.0% | ||
| Q2 24 | -77.4% | -139.2% |
| Q1 26 | -18.5% | -92.6% | ||
| Q4 25 | -5.8% | -83.0% | ||
| Q3 25 | -18.7% | -103.1% | ||
| Q2 25 | -23.6% | -96.1% | ||
| Q1 25 | -40.5% | -151.4% | ||
| Q4 24 | -18.6% | -103.6% | ||
| Q3 24 | -22.7% | -131.2% | ||
| Q2 24 | -67.6% | -110.9% |
| Q1 26 | — | $-0.83 | ||
| Q4 25 | $-0.01 | $-0.73 | ||
| Q3 25 | $-0.03 | $-0.82 | ||
| Q2 25 | $-0.04 | $-0.75 | ||
| Q1 25 | $-0.06 | $-0.81 | ||
| Q4 24 | $-0.03 | $-0.71 | ||
| Q3 24 | $-0.04 | $-0.73 | ||
| Q2 24 | $-0.11 | $-0.55 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $340.6M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | — | $122.9M |
| Total Assets | — | $442.3M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $340.6M | ||
| Q4 25 | $63.3M | $388.9M | ||
| Q3 25 | $56.1M | $416.1M | ||
| Q2 25 | $62.0M | $291.0M | ||
| Q1 25 | $57.3M | $314.5M | ||
| Q4 24 | $45.5M | $320.6M | ||
| Q3 24 | $49.7M | $298.4M | ||
| Q2 24 | $53.0M | $319.1M |
| Q1 26 | — | $122.9M | ||
| Q4 25 | $431.3M | $139.1M | ||
| Q3 25 | $429.7M | $148.8M | ||
| Q2 25 | $429.5M | $-11.9M | ||
| Q1 25 | $436.1M | $18.9M | ||
| Q4 24 | $453.5M | $21.7M | ||
| Q3 24 | $456.0M | $11.2M | ||
| Q2 24 | $472.3M | $39.3M |
| Q1 26 | — | $442.3M | ||
| Q4 25 | $486.8M | $480.2M | ||
| Q3 25 | $488.9M | $506.9M | ||
| Q2 25 | $490.4M | $372.7M | ||
| Q1 25 | $495.0M | $386.7M | ||
| Q4 24 | $514.0M | $392.3M | ||
| Q3 24 | $517.7M | $363.6M | ||
| Q2 24 | $542.1M | $381.8M |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
